In osteoporosis, the density and quality of bone are reduced and become more fragile, with
a significantly increased risk of fracture. Living tissue of bone undergoes continuous …

With an increase in the ageing population worldwide, the prevalence of osteoporosis
increases at an alarming rate in both male and female irrespective of their ethnicity. At …

Background Osteoporosis, the most common and serious skeletal" disease", is highly
prevalent among the elderly of both sexes, with a combined lifetime risk for hip fracture …

Mesenchymal stem cells (MSCs) play an important role in developing bone tissue
engineered constructs due to their osteogenic and chondrogenic differentiation potential …

Osteoporosis is a growing healthcare burden that affects the quality of life in the aging
population. Vitamin E is a potential prophylactic agent that can impede the progression of …

Due to estrogen deficiency, postmenopausal women may suffer from an imbalance in bone
metabolism that leads to bone fractures. Isoflavones, a type of phytoestrogen, have been …

Osteoporosis (OP) is a systemic metabolic skeletal disease which can lead to reduction in
bone mass and increased risk of bone fracture due to the microstructural degradation …

The drugs used for treating bone diseases (BDs), at present, elicit hazardous side effects
that include certain types of cancers and strokes, hence the ongoing quest for the discovery …

Background Age-related estrogen deficiency leads to accelerated bone resorption. There is
evidence that, through selective estrogen receptor modulation, isoflavones may exert …

Osteoblast differentiation plays an essential role in bone integrity. Isoflavones and some
flavonoids are reported to have osteogenic activity and potentially possess the ability to treat …